BeStock  

AptarGroup ATR

US equityMarket cap rank #1511Medical Instruments & Supplies
$140.08 −$0.26 (-0.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $140.08 0.00%
Open$142.35
Prev close$140.34
Day range$139.85 – $143.88
Volume868.1K
Market cap$8.88B
P/E (TTM)33.8
Dividend yield1.37%

Earnings

Average move on report day±4.3%last 16 reports
Closed higher12 of 1675% of the time
Best reaction+8.3%
Worst reaction-10.0%

Stock move on the day after each report

+5.2%2023/Q4+2.2%2024/Q1+3.7%2024/Q2+1.4%2024/Q3-8.5%2024/Q4+2.5%2025/Q1-10.0%2025/Q2-6.7%2025/Q3+8.3%2025/Q4-3.8%2026/Q1+0.1%2026/Q2+5.0%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q329 Oct 2026After Market±5.6%+5.02%Within range
2026/Q230 Jul 2026After Market±7.2%+0.07%Within range
2026/Q130 Apr 2026After Market±5.4%-3.77%Within range
2025/Q45 Feb 2026After Market±5.1%+8.33%Bigger than priced
2025/Q330 Oct 2025None±4.9%-6.71%Bigger than priced
2025/Q231 Jul 2025None±4.9%-10.05%Bigger than priced
2025/Q11 May 2025After Market±6.8%+2.51%Within range
2024/Q46 Feb 2025After Market±6.2%-8.48%Bigger than priced
2024/Q324 Oct 2024After Market±6.7%+1.42%Within range
2024/Q225 Jul 2024After Market±7.0%+3.65%Within range
2024/Q125 Apr 2024After Market±3.5%+2.25%Within range
2023/Q48 Feb 2024After Market±5.5%+5.18%Within range
2023/Q325 Oct 2023After Market±6.8%+0.87%Within range
2023/Q227 Jul 2023After Market±4.5%+3.89%Within range
2023/Q127 Apr 2023After Market–+1.66%–
2022/Q416 Feb 2023After Market–+5.42%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Pharma$454.19M 44.1%
  • Beauty$365.95M 35.5%
  • Closures$209.42M 20.3%

Latest reported quarter: Q3, ended Sep 2026

Revenue$1.02B+6.0% YoY
Operating profit$137.22M-1.3% YoY
Net profit$32.82M-74.3% YoY
Diluted EPS$0.51-73.4% YoY
Free cash flow$97.55M-14.4% YoY
Operating cash flow$167.60M

Revenue, last 8 quarters

$848.1MDec '24$887.3MMar '25$966.0MJun '25$961.1MSep '25$962.7MDec '25$982.9MMar '26$1.0BJun '26$1.0BSep '26

Net profit, last 8 quarters

$100.9MDec '24$78.7MMar '25$111.7MJun '25$127.8MSep '25$74.3MDec '25$72.8MMar '26$88.0MJun '26$32.8MSep '26

Profitability & balance sheet

Gross margin35.8%
Operating margin12.1%
Net margin6.7%
Return on equity9.9%
Return on assets5.2%
Return on invested capital7.6%
Current ratio1.50
Liabilities / assets47.9%
Cash & investments$212.30M
Total debt$1.42B
Net cash (debt)-$1.21B
Free cash flow / sales7.3%

Discussion

No comments yet — be the first to weigh in on ATR.

Sign in to join the discussion.

Scroll to Top